We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-9.76%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$210M
AUM Growth
-$8.84M
Cap. Flow
+$15.6M
Cap. Flow %
7.42%
Top 10 Hldgs %
25.12%
Holding
107
New
6
Increased
45
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$2.36M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$924K
3
CVS icon
CVS Health
CVS
+$731K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$717K
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$689K

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$2.86M
2
GE icon
GE Aerospace
GE
+$1.29M
3
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$951K
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$435K
5
OIH icon
VanEck Oil Services ETF
OIH
+$415K

Sector Composition

Rank Sector Weight
1 Technology 13.92%
2 Healthcare 13.24%
3 Industrials 12.66%
4 Consumer Staples 11.68%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAU icon
51
iShares Gold Trust
IAU
$63.8B
$1.49M 0.71%
60,505
+9,225
+18% +$217K
JNJ icon
52
Johnson & Johnson
JNJ
$617B
$1.21M 0.57%
9,355
– –
CVX icon
53
Chevron
CVX
$383B
$1.12M 0.53%
10,292
+1,100
+12% +$127K
IBB icon
54
iShares Biotechnology ETF
IBB
$9.52B
$1.04M 0.5%
10,814
-1,685
-13% -$179K
T icon
55
AT&T
T
$159B
$956K 0.46%
44,357
-253
-0.6% -$5.89K
CTAS icon
56
Cintas
CTAS
$82.7B
$928K 0.44%
22,120
– –
GOOG icon
57
Alphabet (Google) Class C
GOOG
$4.08T
$894K 0.43%
17,280
-2,100
-11% -$112K
PFE icon
58
Pfizer
PFE
$142B
$880K 0.42%
21,261
– –
VEA icon
59
Vanguard FTSE Developed Markets ETF
VEA
$230B
$865K 0.41%
+23,330
New +$924K
JPM icon
60
JPMorgan Chase
JPM
$933B
$864K 0.41%
8,853
– –
IJH icon
61
iShares Core S&P Mid-Cap ETF
IJH
$122B
$842K 0.4%
25,365
+18,875
+291% +$689K
DIS icon
62
Walt Disney
DIS
$167B
$808K 0.38%
7,371
– –
SYK icon
63
Stryker
SYK
$133B
$710K 0.34%
4,534
– –
VWO icon
64
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$705K 0.34%
+18,520
New +$717K
DUK icon
65
Duke Energy
DUK
$98.4B
$678K 0.32%
7,859
– –
OIH icon
66
VanEck Oil Services ETF
OIH
$2.01B
$642K 0.31%
2,289
-1,050
-31% -$415K
NEE icon
67
NextEra Energy
NEE
$183B
$620K 0.3%
14,280
– –
AOR icon
68
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$608K 0.29%
14,722
– –
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
$564K 0.27%
12,379
+2,390
+24% +$115K
BXP icon
70
Boston Properties
BXP
$11.4B
$545K 0.26%
4,850
– –
ORCL icon
71
Oracle
ORCL
$367B
$522K 0.25%
11,564
– –
LLY icon
72
Eli Lilly
LLY
$1.03T
$520K 0.25%
4,500
– –
SYY icon
73
Sysco
SYY
$40.6B
$513K 0.24%
8,190
– –
BA icon
74
Boeing
BA
$175B
$506K 0.24%
1,571
– –
PAYX icon
75
Paychex
PAYX
$41.4B
$505K 0.24%
7,755
– –
1 2
3
4 5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return
GPA
Guidance Point Advisors Wellesley, Massachusetts $422M AUM 16.47% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return

Boston Research & Management's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Research & Management held 107 positions worth $210M, down 4% from $219M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management deployed $15.6M of net new capital in Q4 2018, opening 6 new positions and adding to 45 existing holdings. Its largest new stake was Linde: 14,930 shares worth $2.33M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $1.29M trimmed.

  • Boston Research & Management's largest Q4 2018 buy was Linde: 14,930 shares worth $2.33M.
  • Boston Research & Management added most to CVS Health in Q4 2018, an estimated $731K increase.
  • Boston Research & Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $1.29M.
  • Boston Research & Management fully exited Praxair Inc in Q4 2018, selling an estimated $2.86M.
  • Boston Research & Management's ten largest holdings make up 25% of its $210M portfolio in Q4 2018.
  • Boston Research & Management opened 6 new positions and closed 7 in Q4 2018.
  • Boston Research & Management's portfolio value fell 4% quarter-over-quarter to $210M.

Based on Boston Research & Management's 13F filing for Q4 2018, filed 6 Feb 2019.